Big Movers on D-St: What should investors do with MindTree, DRL and KEC International?

Big Movers on D-St: What should investors do with MindTree, DRL and KEC International?

The Indian market closed in the red for the third consecutive day on Wednesday. The S&P BSE Sensex fell by nearly 400 points while the Nifty50 closed below 16,000 levels. Sectorally, buying was seen in healthcare, FMCG, metals, and the public sector, while selling was seen in power, utilities, oil & gas, and energy stocks. … Read more

Kunal Bothra’s market outlook & two stock picks for next week

Kunal Bothra’s market outlook & two stock picks for next week

Friday’s move compliments data points on the indices. We also saw a blend of short covering as well as long built up so there were so many large cap names which looked more formidable likes of , Dr Reddy making a comeback, the pharma stocks overall making a comeback and such other sector which did … Read more

India’s vaccination drive picks up for adults but long road ahead for children

India’s vaccination drive picks up for adults but long road ahead for children

Covaxin phase 2/3 studies have been completed for 2 to 17 years age group population and immunogenicity and safety data have been submitted to the Drugs Controller General of India (DCGI) for further approvals. Even as India’s cumulative Covid-19 vaccination coverage exceeds 75.89 Crore, Covid-19 vaccination of children with comorbidities in the 12 to 17 … Read more

DRDO-DRL’s 2DG drug for COVID-19 treatment gets delayed

DRDO-DRL’s 2DG drug for COVID-19 treatment gets delayed

During the surge in cases, those looking for the miracle drug were asked to be in touch with DRL which was sending directly to the hospitals on presentation of the prescriptions. (Photo source: IE) Wait for the 2-deoxy-D-glucose (2-DG), could get longer. This anti-COVID-19 therapeutic drug 2-deoxy-D-glucose (2-DG) was supposed to be available commercially mid-June, … Read more

DRDO’s Covid drug 2-DG expected to be in the market in June, says DRL

DRDO’s Covid drug 2-DG expected to be in the market in June, says DRL

In his address the minister described the 2-DG drug as a new ray of hope in the present challenging times. On Monday, the first batch of the adjunct COVID therapy anti-COVID drug, 2-deoxy-D-glucose (2-DG), was officially released by the defence minister Rajnath Singh. As has been reported earlier this anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose … Read more

COVID-19 vaccine update: Dr Reddy’s Laboratories’ Sputnik V deal raises hopes of vaccine for India by year-end

COVID-19 vaccine update: Dr Reddy’s Laboratories’ Sputnik V deal raises hopes of vaccine for India by year-end

The Sputnik V COVID-19 vaccine has been developed by Moscow’s Gamaleya Research Institute of Epidemiology and Microbiology and it was touted as the “World’s first Coronavirus vaccine” when it received approval for public use in August. (Representational image) COVID-19 vaccine update: In a major boost to the prospects of a Coronavirus vaccine for India, drugmaker … Read more